Protagonist Therapeutics, Inc. (PTGX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 7.44M | 4.71M | 5.55M | 28.32M | 170.64M | 4.67M | 4.17M | 254.95M | 60M | 0 | 0 |
| Revenue Growth % | -100% | -95.64% | 0.79% | 33.09% | -88.89% | 184.4% | - | - | - | - | - | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 7.44M | 4.71M | 5.55M | 28.32M | 170.64M | 4.67M | 4.17M | 254.95M | 60M | 0 | 0 |
| Gross Margin % | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - | - |
| Gross Profit Growth % | -100% | -95.64% | 0.79% | 33.09% | -88.89% | 184.4% | - | - | - | - | - | -100% |
| Operating Expenses | 60.02M | 57.79M | 51.13M | 47.59M | 47.63M | 43.86M | 46.13M | 42.96M | 48.64M | 36.95M | 38.33M | 42.35M |
| OpEx % of Revenue | - | 777.09% | 1085.17% | 858.04% | 168.18% | 25.7% | 986.7% | 1030.96% | 19.08% | 61.59% | - | - |
| Selling, General & Admin | 13.28M | 11.43M | 11.13M | 10.55M | 11.74M | 8.95M | 10.16M | 9.44M | 14.91M | 8.05M | 7.66M | 9.17M |
| SG&A % of Revenue | - | 153.74% | 236.21% | 190.25% | 41.45% | 5.25% | 217.28% | 226.54% | 5.85% | 13.42% | - | - |
| Research & Development | 46.74M | 46.36M | 40M | 37.04M | 35.89M | 34.9M | 35.97M | 33.52M | 33.73M | 28.9M | 30.66M | 33.18M |
| R&D % of Revenue | - | 623.34% | 848.96% | 667.8% | 126.74% | 20.46% | 769.41% | 804.42% | 13.23% | 48.16% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.65M | -50.35M | -46.42M | -42.04M | -19.31M | 126.78M | -41.45M | -38.79M | 206.31M | 23.05M | -38.33M | -42.35M |
| Operating Margin % | - | -677.09% | -985.17% | -758.04% | -68.18% | 74.3% | -886.7% | -930.96% | 80.92% | 38.41% | - | - |
| Operating Income Growth % | 81.11% | -139.72% | -11.98% | -8.37% | -109.36% | 450.05% | -8.16% | 8.41% | 672.75% | 163.12% | -18.65% | -2.2% |
| EBITDA | -3.65M | -49.98M | -46.06M | -41.74M | -19.07M | 127.32M | -40.81M | -37.32M | 206.54M | 23.88M | -37.5M | -41.53M |
| EBITDA Margin % | - | -672.03% | -977.5% | -752.56% | -67.34% | 74.61% | -872.86% | -895.54% | 81.01% | 39.8% | - | - |
| EBITDA Growth % | 80.87% | -139.26% | -12.88% | -11.84% | -109.23% | 433.13% | -8.82% | 10.15% | 686.96% | 166.94% | -19.23% | -2.3% |
| D&A (Non-Cash Add-back) | 0 | 376K | 361K | 304K | 239K | 536K | 647K | 1.48M | 236K | 832K | 827K | 821K |
| EBIT | 0 | -50.35M | -39.34M | -42.04M | -19.31M | 126.78M | -41.45M | -38.79M | 206.31M | 23.05M | -38.33M | -42.35M |
| Net Interest Income | 0 | 6.76M | 7.05M | 7.41M | 7.57M | 6.85M | 7.68M | 7.4M | 4.38M | 4.24M | 4.25M | 3.91M |
| Interest Income | 5.88M | 6.76M | 7.05M | 7.41M | 7.57M | 6.85M | 7.68M | 7.4M | 4.38M | 4.24M | 4.25M | 3.91M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 5.93M | 6.64M | 7.08M | 7.44M | 7.66M | 6.88M | 7.82M | 7.5M | 4.36M | 4.29M | 4.22M | 3.89M |
| Pretax Income | 2.28M | -43.72M | -39.34M | -34.6M | -11.65M | 133.66M | -33.63M | -31.29M | 210.67M | 27.34M | -34.1M | -38.46M |
| Pretax Margin % | - | -587.84% | -834.87% | -623.86% | -41.15% | 78.33% | -719.36% | -750.95% | 82.63% | 45.56% | - | - |
| Income Tax | -1.5M | 666K | 0 | 172K | 0 | 1.99M | -420K | -676K | 3.33M | 0 | 0 | 0 |
| Effective Tax Rate % | -65.85% | -1.52% | 0% | -0.5% | 0% | 1.49% | 1.25% | 2.16% | 1.58% | 0% | 0% | 0% |
| Net Income | 3.78M | -44.38M | -39.34M | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M |
| Net Margin % | - | -596.8% | -834.87% | -626.96% | -41.15% | 77.17% | -710.37% | -734.73% | 81.32% | 45.56% | - | - |
| Net Income Growth % | 132.46% | -133.71% | -18.46% | -13.57% | -105.62% | 381.7% | 2.62% | 20.4% | 714.8% | 179.94% | -9.2% | 6.28% |
| Net Income (Continuing) | 3.78M | -44.38M | -39.34M | -34.77M | -11.65M | 131.67M | -33.21M | -30.62M | 207.34M | 27.34M | -34.1M | -38.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.05 | -0.69 | -0.62 | -0.55 | -0.19 | 1.98 | -0.54 | -0.50 | 3.26 | 0.44 | -0.58 | -0.68 |
| EPS Growth % | 126.32% | -134.85% | -14.81% | -10% | -105.83% | 350% | 6.9% | 26.47% | 625.81% | 168.75% | 4.92% | 18.07% |
| EPS (Basic) | 0.06 | -0.69 | -0.62 | -0.55 | -0.19 | 2.11 | -0.54 | -0.50 | 3.41 | 0.45 | -0.58 | -0.68 |
| Diluted Shares Outstanding | 70.49M | 63.57M | 63.77M | 63.51M | 62.96M | 66.41M | 61.77M | 61.31M | 63.6M | 61.8M | 59.18M | 56.78M |
| Basic Shares Outstanding | 65.09M | 63.57M | 63.77M | 63.51M | 62.96M | 62.33M | 61.77M | 61.31M | 60.86M | 60.39M | 59.18M | 56.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |